Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk

被引:32
作者
Andersson, Patiyan [1 ]
Varenhorst, Eberhard
Soderkvist, Peter
机构
[1] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Cell Biol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Urol, SE-58185 Linkoping, Sweden
关键词
androgen receptor; vitamin D receptor; prostate cancer; CAG repeat;
D O I
10.1016/j.ejca.2006.06.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We study the CAG repeat region in exon 1 of the androgen receptor (AR) and the TaqI polymorphism in exon 9 of the vitamin D receptor (VDR) and the association with prostate cancer. 137 incidentally discovered, histologically verified prostate cancers were analysed for CAG repeat length in AR and genotype at the TaqI site of the VDR. 124 control subjects were analysed to determine the CAG repeat length and TaqI genotype determined for 176 control subjects. An unpaired t-test shows that the mean CAG repeat length was significantly (p < 0.001) shorter among cases (20.1 repeats) compared with controls (22.5 repeats). Dividing the prostate cohort and controls into tertiles (<= 19, 20-22, >= 23 repeats) shows that short repeats are significantly more common among cases (odds ratio (OR) 4.45, p = 0.00003). Genotype frequencies for the TaqI polymorphism reveals no significant differences between cases and controls. We conclude that men with a short CAG repeat in the androgen receptor gene have an increased risk of developing prostate cancer. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2833 / 2837
页数:5
相关论文
共 30 条
  • [1] Blazer DG, 2000, MOL CARCINOGEN, V27, P18
  • [2] THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION
    CHAMBERLAIN, NL
    DRIVER, ED
    MIESFELD, RL
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (15) : 3181 - 3186
  • [3] Chen C, 2002, CANCER EPIDEM BIOMAR, V11, P1033
  • [4] Vitamin D receptor polymorphisms as markers in prostate cancer
    Correa-Cerro, L
    Berthon, P
    Häussler, J
    Bochum, S
    Drelon, E
    Mangin, P
    Fournier, G
    Paiss, T
    Cussenot, O
    Vogel, W
    [J]. HUMAN GENETICS, 1999, 105 (03) : 281 - 287
  • [5] (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
    Correa-Cerro, L
    Wöhr, G
    Häussler, J
    Berthon, P
    Drelon, E
    Mangin, P
    Fournier, G
    Cussenot, O
    Kraus, P
    Just, W
    Paiss, T
    Cantú, JM
    Vogel, W
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (03) : 357 - 362
  • [6] The androgen receptor: genetic considerations in the development and treatment of prostate cancer
    Cude, KJ
    Dixon, SC
    Guo, Y
    Lisella, J
    Figg, WD
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05): : 419 - 426
  • [7] Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO
  • [8] 2-Y
  • [9] Ekman P, 1999, PROSTATE, V39, P262
  • [10] Giovannucci E, 2002, CANCER EPIDEM BIOMAR, V11, P985